Heron Therapeutics | HRTX - Trade Creditors


Heron Therapeutics reported $8.97M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
ALKERMES USD 102.36M 5.59M Mar/2026
Alnylam Pharmaceuticals USD 126.63M 10.91M Mar/2026
Amarin USD 48.15M 2.8M Mar/2026
ANI Pharmaceuticals USD 69.69M 7.11M Mar/2026
Anika Therapeutics USD 6.34M 298K Mar/2026
Arrowhead Research USD 30.75M 2.19M Mar/2026
Eisai JPY 75.89B 9.6B Mar/2026
Emergent BioSolutions USD 112.2M 500K Dec/2023
Esperion Therapeutics USD 68.41M 3.34M Mar/2026
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
Heron Therapeutics USD 8.97M 24K Mar/2026
Insmed USD 73.38M 6.53M Mar/2026
Ligand Pharmaceuticals USD 37.11M 33.87M Mar/2026
Merck USD 3.86B 541M Mar/2026
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
Omeros USD 8.84M 4.42M Jun/2025
Pacira USD 14.01M 1.14M Mar/2026
Regeneron Pharmaceuticals USD 1.03B 4.81B Mar/2026
Roche Holding CHF 5.78B 1.27B Dec/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Surmodics USD 5.93M 3.14M Jun/2025
Ultragenyx Pharmaceutical USD 42M 11M Mar/2026
Veracyte USD 6.91M 2.32M Mar/2026
Vertex Pharmaceuticals USD 3.47B 40.6M Mar/2026